Clin2
NCT06508710Likely a fitRecruiting

Ketamine plus venlafaxine for severe depression

Major Depressive Episode

Treatments studied

Part of Mental health clinical trials.

This trial tests whether adding ketamine to the antidepressant venlafaxine helps relieve severe depression faster than venlafaxine alone. If you are hospitalized for a serious depression and you meet safety criteria, you may be eligible.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
60 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You are currently hospitalized for a severe episode of depression (score of 24 or higher on a depression rating scale).
  • Your doctor plans to start you on the antidepressant venlafaxine.
  • You must not have tried two or more different antidepressants that failed in the past (for this episode).
  • You have no history of bipolar disorder, schizophrenia, or a psychotic depression.
  • You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use effective birth control.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06630065Recruiting
Ketamine study for depression using brain scans

This trial uses brain scans to understand how ketamine affects negative emotions in people with depression. It may help explain why ketamine works and who benefits most.

Paris, Paris
NCT07088380Recruiting· Phase 3
Ketamine combined with ECT for hard-to-treat depression

This trial tests whether adding ketamine to electroconvulsive therapy (ECT) works better than ECT alone for people with depression that hasn't improved with at least two different antidepressants. It may offer a new option for those who have not found relief from standard treatments.

Milan
NCT07683988Not yet recruiting· Phase 1
Ketamine for treatment-resistant depression

This trial tests if ketamine (taken as a pill or under the tongue) can help people with moderate to severe depression that hasn't improved with at least two other antidepressants. The goal is to find out if this approach is safe and effective.

NCT06788249Recruiting· Early Phase 1
Ketamine for treatment-resistant depression brain study

This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.

Philadelphia, Pennsylvania
NCT05327699Recruiting· Early Phase 1
Ketamine study for depression with reduced pleasure

This early-phase study tests whether ketamine can help people with major depression who have trouble feeling pleasure. It also studies how the brain may change in response to stress, to better understand who might respond to treatment.

Atlanta, Georgia
NCT06559826Recruiting· Phase 2
Ketamine therapy with or without talk for depression

This study compares ketamine alone to ketamine combined with psychotherapy for treating depression. It may help if you have moderate to severe depression and want to see if adding talk therapy improves results.

New York, New York

Hear when a new Major Depressive Episode trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.